• Citer

Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.

par Mulkay, Jean-Pierre ;Louis, Hubert ;Donckier De Donceel, Vincent ;Bourgeois, Nadine ;Adler, Michael ;Devière, Jacques ;Le Moine, Olivier
Référence Acta gastro-enterologica Belgica (Ed. multilingue), 64, 1, page (15-19)
Publication Publié, 2001

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Hepatorenal syndrome (HRS) is a severe complication of liver cirrhosis. Recently, ornipressin, a potent splanchnic vasoconstrictor, was reported to improve renal function in patients with HRS. However, this treatment is associated with a high incidence of vascular complications. Terlipressin is thought to be as effective as ornipressin with less systemic complications.